Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882

Watchlist Manager
Guangzhou Kingmed Diagnostics Group Co Ltd Logo
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Watchlist
Price: 31.45 CNY -6.81% Market Closed
Market Cap: 14.6B CNY
Have any thoughts about
Guangzhou Kingmed Diagnostics Group Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Guangzhou Kingmed Diagnostics Group Co Ltd

Wall Street analysts forecast Guangzhou Kingmed Diagnostics Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Guangzhou Kingmed Diagnostics Group Co Ltd is 34.23 CNY with a low forecast of 26.77 CNY and a high forecast of 43.05 CNY.

Lowest
Price Target
26.77 CNY
15% Downside
Average
Price Target
34.23 CNY
9% Upside
Highest
Price Target
43.05 CNY
37% Upside
Guangzhou Kingmed Diagnostics Group Co Ltd Competitors:
Price Targets
ADUS
Addus Homecare Corp
14% Upside
LALPATHLAB
Dr. Lal PathLabs Ltd
5% Upside
WELL
WELL Health Technologies Corp
51% Upside
AMED
Amedisys Inc
10% Upside
BDSX
Biodesix Inc
147% Upside
DVA
DaVita Inc
2% Downside
600763
Topchoice Medical Co Inc
5% Upside
ATRY
Atrys Health SA
88% Upside

Revenue
Forecast

Revenue Estimate
Guangzhou Kingmed Diagnostics Group Co Ltd

For the last 8 years the compound annual growth rate for Guangzhou Kingmed Diagnostics Group Co Ltd's revenue is 17%. The projected CAGR for the next 3 years is 9%.

17%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Guangzhou Kingmed Diagnostics Group Co Ltd

For the last 8 years the compound annual growth rate for Guangzhou Kingmed Diagnostics Group Co Ltd's operating income is 13%. The projected CAGR for the next 3 years is 34%.

13%
Past Growth
34%
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Guangzhou Kingmed Diagnostics Group Co Ltd

For the last 8 years the compound annual growth rate for Guangzhou Kingmed Diagnostics Group Co Ltd's net income is 22%. The projected CAGR for the next 3 years is 19%.

22%
Past Growth
19%
Estimated Growth
Estimates Accuracy
1%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Guangzhou Kingmed Diagnostics Group Co Ltd's stock price target?
Price Target
34.23 CNY

According to Wall Street analysts, the average 1-year price target for Guangzhou Kingmed Diagnostics Group Co Ltd is 34.23 CNY with a low forecast of 26.77 CNY and a high forecast of 43.05 CNY.

What is Guangzhou Kingmed Diagnostics Group Co Ltd's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Guangzhou Kingmed Diagnostics Group Co Ltd's revenue is 17%. The projected CAGR for the next 3 years is 9%.

What is Guangzhou Kingmed Diagnostics Group Co Ltd's Operating Income forecast?
Projected CAGR
34%

For the last 8 years the compound annual growth rate for Guangzhou Kingmed Diagnostics Group Co Ltd's operating income is 13%. The projected CAGR for the next 3 years is 34%.

What is Guangzhou Kingmed Diagnostics Group Co Ltd's Net Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Guangzhou Kingmed Diagnostics Group Co Ltd's net income is 22%. The projected CAGR for the next 3 years is 19%.

Back to Top